MENU
ESPR
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Esperion Therapeutics (ESPR) Earnings Date & Reports

Esperion Therapeutics Inc is a pharmaceutical company... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

ESPR is expected to report earnings to fall 235.50% to 2 cents per share on November 05

Esperion Therapeutics ESPR Stock Earnings Reports
Q3'25
Est.
$0.03
Q2'25
Beat
by $0.12
Q1'25
Missed
by $0.05
Q4'24
Beat
by $0.03
Q3'24
Beat
by $0.03
The last earnings report on August 05 showed earnings per share of -1 cents, beating the estimate of -14 cents. With 5.52M shares outstanding, the current market capitalization sits at 410.41M.
View a ticker or compare two or three
ESPR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ESPR showed earnings on August 05, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a developer of biopharmaceutical products

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
Biotechnology
Address
3891 Ranchero Drive
Phone
+1 734 887-3903
Employees
240
Web
https://www.esperion.com